331 related articles for article (PubMed ID: 37204745)
1. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update.
Favaloro EJ; Mohammed S; Vong R; Pasalic L
Methods Mol Biol; 2023; 2663():679-691. PubMed ID: 37204745
[TBL] [Abstract][Full Text] [Related]
2. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
4. Von Willebrand disease type 2N: An update.
Seidizadeh O; Peyvandi F; Mannucci PM
J Thromb Haemost; 2021 Apr; 19(4):909-916. PubMed ID: 33497541
[TBL] [Abstract][Full Text] [Related]
5. Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment?
Seidi Zadeh O; Ahmadinejad M; Amoohossein B; Homayoun S
Blood Coagul Fibrinolysis; 2020 Sep; 31(6):382-386. PubMed ID: 32815913
[TBL] [Abstract][Full Text] [Related]
6. Periprocedural management of type 2N von Willebrand disease with efanesoctocog alfa.
Ryu JH; Bauer KA; Schulman S
J Thromb Haemost; 2023 Dec; 21(12):3508-3510. PubMed ID: 37734716
[TBL] [Abstract][Full Text] [Related]
7. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD).
Mohammed S; Favaloro EJ
Methods Mol Biol; 2017; 1646():461-472. PubMed ID: 28804848
[TBL] [Abstract][Full Text] [Related]
8. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice.
Swystun LL; Georgescu I; Mewburn J; Deforest M; Nesbitt K; Hebert K; Dwyer C; Brown C; Notley C; Lillicrap D
J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694
[TBL] [Abstract][Full Text] [Related]
9. Type 2N von Willebrand disease: Characterization and diagnostic difficulties.
Casonato A; Galletta E; Sarolo L; Daidone V
Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations.
Boylan B; Rice AS; De Staercke C; Eyster ME; Yaish HM; Knoll CM; Bean CJ; Miller CH;
J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857
[TBL] [Abstract][Full Text] [Related]
11. The Lesson Learned from the New c.2547-1G > T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect.
Casonato A; Cozzi MR; Ferrari S; Rubin B; Gianesello L; De Marco L; Daidone V
Thromb Haemost; 2022 Sep; 122(9):1479-1485. PubMed ID: 35189660
[TBL] [Abstract][Full Text] [Related]
12. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees.
Qin HH; Xing ZF; Wang XF; Ding QL; Xi XD; Wang HL
Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655
[TBL] [Abstract][Full Text] [Related]
13. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project.
Pérez-Rodríguez A; Batlle J; Pinto JC; Corrales I; Borràs N; Garcia-Martínez I; Cid AR; Bonanad S; Parra R; Mingot-Castellano ME; Navarro N; Altisent C; Pérez-Montes R; Moretó A; Herrero S; Soto I; Mosteirín NF; Jiménez-Yuste V; Jacob AA; Fontanes E; Mateo J; Quismondo NC; Batlle F; Vidal F; López-Fernández MF;
Haemophilia; 2021 Nov; 27(6):1007-1021. PubMed ID: 34494337
[TBL] [Abstract][Full Text] [Related]
14. Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype.
van Meegeren ME; Mancini TL; Schoormans SC; van Haren BJ; van Duren C; Diekstra A; Laros-van Gorkom BA; Brons PP; Simons A; Hoefsloot L; van Heerde WL
Haemophilia; 2015 Sep; 21(5):e375-83. PubMed ID: 26207643
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of factor VIII binding activity of von Willebrand factor by means of an ELISA method: significance and practical implications.
Casonato A; Pontara E; Zerbinati P; Zucchetto A; Girolami A
Am J Clin Pathol; 1998 Mar; 109(3):347-52. PubMed ID: 9495210
[TBL] [Abstract][Full Text] [Related]
16. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1.
Michiels JJ; Gadisseur A; Vangenegten I; Schroyens W; Berneman Z
Acta Haematol; 2009; 121(2-3):119-27. PubMed ID: 19506358
[TBL] [Abstract][Full Text] [Related]
17. A novel mouse model of type 2N VWD was developed by CRISPR/Cas9 gene editing and recapitulates human type 2N VWD.
Shi Q; Fahs SA; Mattson JG; Yu H; Perry CL; Morateck PA; Schroeder JA; Rapten J; Weiler H; Montgomery RR
Blood Adv; 2022 May; 6(9):2778-2790. PubMed ID: 35015821
[TBL] [Abstract][Full Text] [Related]
18. Large experience with a factor VIII binding assay of plasma von Willebrand factor using commercial reagents.
Caron C; Mazurier C; Goudemand J
Br J Haematol; 2002 Jun; 117(3):716-8. PubMed ID: 12028048
[TBL] [Abstract][Full Text] [Related]
19. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.
Lapić I; Radić Antolic M; Boban A; Coen Herak D; Rogić D; Zadro R
Croat Med J; 2022 Apr; 63(2):166-175. PubMed ID: 35505650
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII and von Willebrand factor changes after desmopressin and during pregnancy in type 2M von Willebrand disease Vicenza: a prospective study comparing patients with single (R1205H) and double (R1205H-M740I) defect.
Castaman G; Federici AB; Bernardi M; Moroni B; Bertoncello K; Rodeghiero F
J Thromb Haemost; 2006 Feb; 4(2):357-60. PubMed ID: 16420565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
